Stock 3759 PHARMARON BEIJING CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Pharmaron Beijing Co., Ltd. Hong Kong S.E.

Equities

3759

CNE100003PG4

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:05 2024-05-31 EDT 		5-day change 1st Jan Change
9.83 HKD +2.50% Intraday chart for Pharmaron Beijing Co., Ltd. -4.00% -37.86%
05-20 Pharmaron Beijing Unit to Sell Proteologix Stake to Johnson & Johnson MT
05-16 Johnson & Johnson entered into a definitive agreement to acquire Proteologix, Inc. from Pharmaron Beijing Co., Ltd and other shareholders for approximately $100 million. CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. 300759 Stock
  4. 3759 Stock
  5. Revisions Pharmaron Beijing Co., Ltd.